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doi‘‘And immediately something like scales fell from his eyes’’
The New Testament. Acts 9:v.19a Chambers Dictionary ‘a slew’: (N Am colloq) n a large number or amount (Irish
slua a multitude).1. Introduction
The proposition that women invited for mammography
screening have not been provided with ‘the facts’ has been
disputed and debated over many years, usually on the basis of
questioning or criticising the scientiﬁc correctness of the data.
The most recent paper questioning ‘the facts’1 reiterated the ﬁnd-
ings from the updated Cochrane systematic review,2 that if 2000
women are screened regularly for ten years, one will beneﬁt
from the screening, as she will avoid dying from breast cancer,
but that, at the same time, ten healthy women will, as a conse-
quence, become ‘‘cancer patients’’ and will be treated unneces-
sarily. Furthermore, it reminded that 200 screened women out
of 2000 will experience a false alarm, where the psychological
strain until the woman knows whether it was cancer, and even
afterwards, can be severe.
It is now time for everyone to consider an equally important
matter: the ‘rightness’ not just of the data itself, but of the behav-
iours of those people and organisations who, in spite of this
compelling evidence, continue to advocate and defend population
screening programmes and the content and quality of information
material provided to the women invited.3 Their denials and justi-
ﬁcations for continuation of the old unethical and patronising
ways must continue to be countered. Outrageous demands of
those in power for increasingly damaging proposals in the US
for the early detection of breast cancer, including teaching
secondary students about breast awareness,4 which are both
unscientiﬁcally founded and ‘wrong’ in the moral sense of that
word, must be strenuously resisted. Any agent who proposes or
supports public policies (based on belief) that will cause more
harm than beneﬁt; will cause known physical and psychological
harms; that undermine respect for individuals; that will unneces-
sarily heighten fear of disease; must be challenged. As Jorgensen
and colleagues have so cogently argued in a recent paper in the
Journal of Medical Ethics5 ‘‘Informed choice requires information
about both beneﬁts and harms; incorrect premises lead to wrong
conclusions; ﬂawed information leads to false expectations; what
you don’t know about you cannot complain about; and full and
understandable information is a requirement, not an option.’’ The
currently occurring ‘short-circuiting’ of the decision-making3-9191/$ – see front matter  2009 Surgical Associates Ltd. Published by Elsevier Lt
:10.1016/j.ijsu.2009.04.006process in screening must be remedied, they suggest, by sepa-
rating the responsibility for the screening programmes from the
responsibility for the information material.2. The public challenge
The decision to scrap the NHS BSP (National Heath Service
Breast Screening Programme) leaﬂet at a hurriedly called Press
Conference6 arranged by the NHS BSP with the Department of
Health, the day after publication of a letter and associated articles
in The Times of 19th February 2009,7 signalled recognition that
the challenges in our letter had been recognised. Whether they
will be properly met remains to be seen, seeing that the New York
Times reported that Julietta Patnick had said that information about
over-diagnosis might be added.8 It was reported in The Times9 that
the UK Director of Cancer Screening Services, Professor Mike
Richards, had said that the leaﬂet Breast Screening: The Factswould
be scrapped, even though he disputed the numbers quoted in our
letter. He also alleged that: ‘‘there are no doubts about the bene-
ﬁts’’. Yet no evidence has been provided about that, either by
him, or the NHS BSP, or for their belief that the ratio was nearer
‘one to one’, or data to support their oft-repeated ‘estimate’ that
‘screening saves 1400 lives a year’. The Times letter [7] had been
signed by a slewa of 23 international health professionals10 from
a multitude of disciplines as well as lay people. The challenge in
that letter that ‘‘none of the invitations for screening comes close to
telling the truth. As a result, women are being manipulated, albeit
unintentionally, into attending’’ had ﬁnally and dramatically hit
home, and caused scales to fall from many eyes.3. Recent denials about ‘telling the truth’
Recent opportunities for both the NHS BSP and Breast Cancer
Care to consider whether ‘the truth’ has been told have been
squandered. For example, rather than engaging in reasoned
debate about the issue on hand, leading ofﬁcials of Breast Cancer
Care presented an ad hominem argument and an irrelevantd. All rights reserved.
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Breast Cancer Care – an organisation widely recognised and
valued for the valuable help and support it provides for women
with breast cancer. The substance of the claim that the slogan
‘‘1 in 9’’12 had been not only been misused, but had also been
used by them on grounds of consistency and popularity,13 was
not addressed. Subverting the process of proving or disproving
the claim, by presenting red herrings, was ill-judged, ill-timed
and regrettable. No evidence to support numbers such as ‘‘1 in
9’’, inappropriately used by these organisations, or other sound
argument to counter such scare-mongering tactics, was provided.
That Breast Cancer Care has produced award-winning publica-
tions (as well as an ill-advised, hastily withdrawn (November
2008) booklet on Complementary Therapies)14 is undoubted, but
provides no proper defence or enlightenment with respect to
consideration of the speciﬁc subject in hand.b Consent to quote this e-mail was sought and obtained from this health
professional.4. Opening the eyes of the public – and health professionals
There is now a willingness by many health professionals and
members of the public to consider the statements, fully supported
by data, that not only there are serious harms associated with
providingmammographic screening to a population, as undertaken
by the NHS BSP, but that their approach to women is seriously
ﬂawed and unacceptable. People – professional and lay – are also
giving consideration to the accusation that for public health ofﬁ-
cials to continue to promote breast screening through information
leaﬂets that have scarcely changed in content over the last 20 years,
in spite of the availability of robust evidence through systematic
reviews, and advances in communication methods, and in spite of
repeated pleas over many years to reconsider their mode of invita-
tion, is unacceptable andmorally wrong. Continued denial by those
in the business of screening and its promotion and advocacy must
continue to be vigorously challenged.
Following the wide publicity given by the media to the gauntlet
thrown down in The Times letter, on 31st March 2009 the author of
this article was helping to train health professionals in an NIHR CRN
(National Institute of Health Research Cancer Research Network)
module on ‘Valid Informed Consent’, ironically in Leeds, UK, the
home-town of the NHS BSP. The course organiser displayed the
article8 on the lecture room screen so that the forty or so attendees
could read the piece Beneﬁts of Mammogram Under Debate in Britain
for themselves, published that day in the New York Times. Some
gasped in astonishment on reading that Julietta Patnick, the
director of the NHS BSP had said in a telephone interview with
the New York Times that ‘‘she dismissed the Cochrane ﬁgures as inac-
curate. British studies, she said, show that the ratio of lives saved to
lives unnecessarily disrupted is more like one to one.’’ No basis or
reference citation for this ratio derived from ‘British studies’ has
been provided as far as I am aware. Perhaps we should at least be
thankful that existence of a beneﬁt to harm ratio has at last been
acknowledged? Calculating the exact ratio is a matter for both thor-
ough, transparent and careful systematic review of the data, as well
as use of ﬁne judgement. That the ratio of harms is greater than the
beneﬁts is indisputable, even if other reputable and robust system-
atic reviews have arrived at slightly different numbers from the
Cochrane ﬁgures, much greater than ‘one to one’. Unless the NHS
BSP provide supporting data for the numbers they use, their cred-
ibility will continue to diminish and public trust and conﬁdence in
the organisation will suffer.
One of the health professionals attending the NIHR CRN course
was moved to e-mail me early the following morning:
‘‘I attended the Valid Informed Consent course at Leeds on the
31st March, and I just wanted to say ‘‘Thank you’’ for all of theinformation you gave. I forwarded your NY Times article to my
Mum, as I knew that she’d recently been for a mammography –
she later told me that she’s actually been taking part in research
for the past 10 yrs onwhether its better to start breast screening
at 40, rather than 50. She has never told me this, and she
also admitted that she’s never had any feedback on the results
of the study either! I’m hoping that she still has the
information sheet she was given 10 yrs ago, and I’ll be encour-
aging her to contact them to get the feedback. I just wanted to
let you know that your talk really opened my eyes, as I’d
never even known about the harms of breast screening. Its
something that I want to make sure every woman in my family
is aware of.’’b
In conclusion, what better conﬁrmation of the worthwhileness
and ‘rightness’ of our challenge could there be than this unsolicited,
impassionedmessage from a young health professional whose eyes
had been suddenly opened? It gave fresh hope and revived the
spirit of this scarred and foot-sore traveller on the long Damascus
Road.
‘‘New occasions teach new duties: Time
makes ancient good uncouth;
They must upward still, and onward,
who would keep abreast of truth.’’
James Russel Lowell, 1819–1891
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